News
The FDA is requiring COVID vaccine makers Pfizer and Moderna to update their warnings about the possible risk of myocarditis and pericarditis.
The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
In this week’s edition of InnovationRx, we look at the FDA's new rules on Covid-19 vaccines, Novartis’s acquisition strategy, ...
The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 ...
Top health officials were aware of and actively took steps to “delay warning the public” for months in 2021 about the potential risks of patients suffering from heart-related ...
U.S. health officials knew about the risks of myocarditis from COVID-19 vaccines but downplayed the concern and delayed informing the public about the risks of taking the jab—that is according to a ...
11h
Zacks.com on MSNMRNA, PFE Stocks Jump Despite FDA's Stricter Standards for COVID-19 ShotsThough the new FDA rules limit access to COVID-19 booster vaccines, the commitment to high-risk groups lifts Moderna, Pfizer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results